Protective Effect of an Elastase Inhibitor in a Neuromyelitis Optica-Like Disease Driven by a Peptide of Myelin Oligodendroglial Glycoprotein

Multiple Sclerosis - United States
doi 10.1177/1352458512440060
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Neuromyelitis Optica

Journal of Neuro-Ophthalmology
MedicineOphthalmologyNeurology
2017English

C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model

Frontiers in Pharmacology
Pharmacology
2019English

Devic’s Neuromyelitis Optica: A Critical Review

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2008English

Effectiveness of Rituximab in Neuromyelitis Optica: A Meta-Analysis

BMC Neurology
MedicineNeurology
2019English

Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica

JAMA Neurology
Neurology
2013English

Seasonality of 278 Neuromyelitis Optica Relapses in a Brazilian Cohort

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2015English

Neuromyelitis Optica Spectrum Disorder in Childhood (A Case Report)

Russkii Zhunal Detskoi Nevrologii
Child HealthNeurologyPediatricsPerinatology
2017English

Altered Neurovascular Coupling in Neuromyelitis Optica

Human Brain Mapping
Nuclear MedicineRadiologyUltrasound TechnologyAnatomyRadiologicalNeurologyImaging
2018English

A Very Special and Rare Case of Neuromyelitis Optica

Journal of Translational Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy